Bnp Paribas Asset Management Holding S.A. Xenon Pharmaceuticals Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 661,082 shares of XENE stock, worth $28.7 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
661,082
Previous 703,795
6.07%
Holding current value
$28.7 Million
Previous $23.6 Million
12.37%
% of portfolio
0.05%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding XENE
# of Institutions
223Shares Held
72.7MCall Options Held
336KPut Options Held
309K-
Avoro Capital Advisors LLC New York, NY5.4MShares$235 Million3.08% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.34MShares$188 Million1.31% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$157 Million6.91% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$155 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$138 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.7B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...